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ABSTRACT 
To investigate the subchronic effect of cadmium intoxication on lipid metabolism and the in-
flammatory responses accompanying it, rats were administered 50 and 100 ppm cadmium 
through their drinking water for 7 weeks. At both concentrations, cadmium exposure resulted 
in significant elevation (p < 0.05) of total cholesterol and gave rise to hypertriglyceridemia in 
the plasma of the animals. The proinflammatory cytokines, IL-2, IL-6 and TNF-α, were high-
ly expressed in the animals. At the 50 ppm dose level, plasma IL-2, IL-6 and TNF-α levels 
were increased by 20 %, 87 % and 336 % respectively, while the 100 ppm dose yielded 32 %, 
57 % and 470 % increases, respectively. A drastic build-up of MDA in the liver elicited by 
the metal led to an 85 % increase in lipid peroxidation at high dose. A 3-fold increase of lipid 
hydroperoxidation (LOOH) products was obtained on exposure to cadmium at 100 ppm. 
Cadmium caused more than a 2-fold increase in oxLDL levels at both doses tested. 
Paraoxonase activity was also significantly repressed, culminating in a 43 % reduction in ac-
tivity at 100 ppm dose. Disruption of lipid metabolism, increased lipid peroxidation as well as 
imbalance in proinflammatory cytokine levels may thus, be means by which cadmium induc-
es its toxicity. 
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INTRODUCTION 
Cadmium is a toxic heavy metal that is 
widely distributed in the environment. It is 
naturally found in the environment as a 
constituent of ocean water and to a lesser 
level in surface water and groundwater 
(ATSDR, 2008). It can be naturally emitted 
into the environment through volcanic ac-
tivities, forest fires, and generation of sea 
salt aerosols (ATSDR, 2008). Anthropo-
genically, cadmium is introduced into the 
environment as a result of non-ferrous min-
ing and refining processes, manufacture and 
application of phosphate fertilizers, fossil 
fuel combustion and manufacture and use 
of nickel-cadmium batteries (Järup, 2003; 
Zhang et al., 2008). Because of its wide ap-
plication in industrial processes, cadmium 
has become one of the most important envi-
ronmental pollutants in the world. One ma-
jor route of exposure is the gastrointestinal 
ingestion of the metal through food and 
drinking water, especially in non-smoking 
and non-occupationally exposed popula-
tions (ATSDR, 2008). Cadmium exposure 
results in accumulation of the metal in sen-
sitive target organs and the metal has been 
shown to affect cell physiology and growth 
(Ramirez and Giménez, 2002; Lafuente et 
al., 2003).  
Studies have linked environmental and 
occupational cadmium exposure with car-
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diovascular disease mortality (Nakagawa et 
al., 2006; Nawroth et al., 2008). Heavy 
metals are generally immunotoxic, among 
the many effects displayed (Villanueva et 
al., 2000) and cadmium especially, has been 
demonstrated to induce disorders in the 
humoral and cellular immune responses 
(Kataranovski et al., 1998; Dan et al., 2000; 
Marth et al., 2000). Cytokines, which are 
mediators of inflammatory and immune re-
actions, are known to alter endothelium 
functions (Ait-Oufella et al., 2011). They 
also induce the expression of chemokines 
and adhesion molecules on the vascular en-
dothelium (Weber et al., 2008). They are 
normally produced as part of the immune 
system but excessive secretion in response 
to several agents, such as microorganisms 
and their products as well as xenobiotics 
can lead to immune cell dysfunctions 
(Shook and Laskin, 1994; Weglarz et al., 
2006). However, there is a paucity of data 
regarding cytokine response during cadmi-
um exposure.  
Information on the effects of cadmium 
on cardiovascular system and its attendant 
inflammatory response is sparse; this study 
was, therefore, undertaken to evaluate the 
effect of sub-chronic cadmium exposure in 
drinking water on the plasma lipids, lipo-
protein contents and cytokine levels in rats. 
 
MATERIALS AND METHODS 
Animals and treatment 
Twenty four male Wistar rats (bred in 
the Animal House of the Faculty of Basic 
Medical Sciences, Ladoke Akintola Univer-
sity of Technology, Ogbomoso, Nigeria) 
with body weight between 120 and 140 g 
were used for the experiment. The animals 
were housed in clean plastic cages and 
maintained on a standard pellet diet and dis-
tilled water ad libitum. They were allowed 
to acclimatize for 2 weeks, after which, the 
body weight was recorded and the rats were 
randomly picked into three groups, com-
prised of eight animals each. Group one 
served as the control, while the rats in 
groups two and three were exposed to cad-
mium in the form of cadmium chloride in 
their drinking water at 50 and 100 ppm 
concentration respectively for 7 weeks. 
Although the levels far exceeded cadmium 
levels to which humans are exposed to in 
food and water (EFSA, 2009; WHO, 2011), 
the concentrations represented levels of 
cadmium that have been reported in litera-
ture to have elicited toxic effects in rats 
(Waalkes and Rehm, 1992; Lafuente et al., 
2004). At the end of cadmium exposure, the 
rats were fasted overnight and the body 
weights were recorded. Blood was collected 
from the animals into heparinized tubes by 
cardiac puncture under light diethyl ether 
anesthesia. The blood samples were centri-
fuged at 2000 x g for 10 minutes to obtain 
the plasma. All samples were stored 
at -20 °C until biochemical analyses were 
performed.  
 
Biochemical analyses 
Plasma concentrations of total choles-
terol, triglyceride and phospholipids were 
determined with commercial kits (Cheme-
lex®, Barcelona, Spain). HDL cholesterol 
and triglycerides were analyzed with the 
same commercial kits for total cholesterol 
and triglycerides after very low density lip-
oproteins (VLDL) and LDL were precipi-
tated with heparin-MnCl2 solution as de-
scribed by Gidez et al. (1982). LDL and 
VLDL cholesterol was estimated by sub-
tracting HDL cholesterol from total choles-
terol. Plasma oxidized LDL (oxLDL) con-
centrations were measured using the meth-
od described by Ahotupa and Vasankari 
(1999). Briefly, buffered heparin (0.064 M 
trisodium citrate adjusted to pH 5.05 with 5 
M HCl, and containing 50000 IU/L hepa-
rin) was used to precipitate LDL. Insoluble 
lipoproteins were sedimented by centrifuga-
tion at 1000×g for 10 min and the pellet 
was resuspended in 1.0 mL of 0.1 M sodi-
um phosphate buffer (pH 8.0, containing 
0.9 % NaCl). Lipids were extracted from 
100 μL of LDL by chloroform/methanol, 
dried under nitrogen, redissolved in cyclo-
hexane and analyzed spectrophotometrical-
ly at 234 nm. A molar absorption coeffi-
cient of 2.95×104 M−1cm−1 was used for 
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calculations. Level of lipid peroxidation 
was measured by the method of Ohkawa et 
al. (1979). Briefly, 0.2 ml of tissue homog-
enate was added to the reaction mixture 
consisting of 0.2 ml 8 % SDS, 1.5 ml 20 % 
acetic acid and 0.6 ml distilled water. Reac-
tion was initiated by adding 1.5 ml of 1 % 
TBA and terminated by 10 % TCA. The 
mixture was then centrifuged and absorb-
ance of the supernatant was read at 532 nm. 
LPO was expressed in terms of nmoles 
MDA formed/mg tissue using an extinction 
coefficient of 1.56×105 M−1 cm−1. Lipid hy-
droperoxides in plasma were assayed by the 
method of Nourooz-Zadeh et al. (1994). 
Samples (90 μl) of plasma were mixed with 
either 10 μl of 10 mM triphenylphosphine 
(TPP) in methanol or with 10 μl of metha-
nol and incubated for 30 min at a room 
temperature. Then, 900 μl of FOX2 reagent 
(250 μM ammonium ferrous sulfate, 
100 μM. xylenol orange, 25 mM H2SO4 and 
4 mM butylated hydroxytoluene in 90 % 
methanol) was added and the sample was 
incubated for another 30 min. The mixture 
was centrifuged at 12 000 × g for 10 min to 
remove flocculated material and the ab-
sorbance was read at 560 nm. The absorb-
ance of the sample with TPP was subtracted 
from the sample without TPP and hydro-
peroxides concentration was calculated 
from the standard curve prepared using dif-
ferent concentrations (1–20 μM) of H2O2. 
The paraoxonase activity of PON1 was de-
termined using paraoxon (O, O-diethyl-o-p-
nitrophenylphosphate) as the substrate. The 
increase in absorbance at 405 nm due to the 
formation of 4-nitrophenol following the 
hydrolysis of paraoxon was measured as 
described by Furlong et al. (1989). The mo-
lar extinction co-efficient of 18050 M-1cm-1 
was used to calculate enzyme activity. 
Plasma concentrations of interleukin 2 (IL-
2), 6 (IL-6) and Tumor Necrosis Factor-
alpha (TNF-α) were analyzed by enzyme-
linked immunosorbent assay (ELISA) 
methods with commercially available assay 
kits (RayBiotech, Inc. USA). 
 
Statistical evaluation 
Results are expressed as mean ± S.E. 
One-way analysis of variance (ANOVA) 
followed by Tukey’s test was used to ana-
lyze the results with p < 0.05 considered 
significant.  
 
RESULTS 
The administration of Cd through drink-
ing water caused distortion in the plasma 
lipid contents of the treated animals com-
pared to control. Cadmium exposure at the 
two levels of concentration tested resulted 
in significantly increased plasma total cho-
lesterol, triglyceride, and (LDL+VLDL)-
cholesterol fraction concentrations when 
compared with control (Table 1). There was 
a steady increase in plasma cholesterol on 
exposure to 50 ppm cadmium which was 
sustained in the 100 ppm cadmium-exposed 
animals (p < 0.05). Cadmium-exposure in-
duced hypertriglyceridemia in the animals 
with 50 % and 146 % increases observed at 
50 and 100 ppm level respectively (p < 
0.05). The phospholipid content in the 
plasma was disturbed by cadmium intoxica-
tion. Exposure to cadmium at 50 ppm level 
resulted in a 25 % depletion of the lipid 
while 100 ppm caused a significant 34 % 
increase (p < 0.05) in concentration. In the 
HDL particles, there were no significant 
differences in the cholesterol and phospho-
lipid contents between control and cadmi-
um-exposed animals.  
Cytokine levels were increased signifi-
cantly (p < 0.05) by cadmium at all concen-
trations employed in the study (Table 1). 
There were significant increases in IL-2 
concentrations on exposure to cadmium at 
both 50 and 100 ppm levels. With IL-6, the 
increase in concentration was higher in the 
50 ppm group, giving an 87 % elevation 
above the control. However, the increase 
elicited by exposure to 100 ppm cadmium 
was not as much, with a yield of 57 % 
above the control. Cadmium administration 
elicited a dose dependent increase in TNF-α 
concentrations. Exposure to 50 and 
100 ppm cadmium resulted in 4- and 6-fold 
increases respectively. 
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Table 1: Effect of cadmium on plasma lipids and lipoproteins, oxLDL and plasma cytokine levels 
Parameters Control 50 ppm 100 ppm 
Total cholesterol (mg/dl) 53.04 ± 0.61a 63.77 ± 0.70 b 80.63 ± 2.38 c 
(LDL+VLDL) cholesterol (mg/dl) 17.61 ± 0.58 a 27.47 ± 0.82b 42.13 ± 1.72 c 
HDL cholesterol (mg/dl) 35.43 ± 0.54 a 36.30 ± 0.95 a 38.50 ± 1.05 a 
Triglycerides (mg/dl) 48.93 ± 0.91 a 73.25 ± 3.13b 120.50 ± 2.11 c 
Phospholipids (mg/dl) 76.13 ± 1.25 a 57.58 ± 2.07 b 102 ± 5.89 c 
HDL phospholipid (mg/dl) 13.75 ± 1.16 a 14.17 ± 0.71 a 13.68 ± 0.53 a 
oxLDL (μmol/l) 3.29 ± 0.22 a 7.38 ± 0.14 b 8.61 ± 0.16 c 
IL-2 (pg/ml) 38.81 ± 3.68a 46.40 ± 5.56b 51.13 ± 7.50b 
IL-6 (pg/ml) 188.99 ± 7.14a 353.33 ± 29.90b 296.26 ± 10.37c 
TNF-α (pg/ml) 71.33 ± 8.28a 310.67 ± 7.04b 407.22 ± 10.78c 
Values are represented as mean ± SEM, n=8. Rows of the same compartment carrying different 
letters of the alphabet are significantly different from each other (p < 0.05). 
 
 
 
Cadmium produced significant increas-
es in MDA levels in the liver, producing 
67 % and 85 % increases at the 50 and 
100 ppm exposure level respectively (Fig-
ure 1).  
 
 
Figure 1: Lipid peroxidation levels in the liver of 
rats exposed to cadmium in their drinking water. 
Values are represented as mean ± SEM, n=8. 
Bars of the same compartment carrying 
different letters of the alphabet are significantly 
different from each other (p < 0.05). 
 
These increases were accompanied by 
elevation in plasma lipid hydroperoxide 
contents with a 1.6-fold increase obtained at 
50 ppm cadmium exposure level and a 3-
fold increase with the 100 ppm level (Fig-
ure 2).  
 
 
Figure 2: Lipid hydroperoxide concentrations in 
plasma of rats exposed to cadmium in their 
drinking water. Values are represented as 
mean ± SEM, n=8. Bars of the same compart-
ment carrying different letters of the alphabet 
are significantly different from each other (p < 
0.05). 
 
OxLDL levels were significantly (p < 
0.05) elevated in the plasma by 124 % and 
162 % on cadmium exposure at 50 and 
100 ppm, respectively (Table 1). The activi-
ty of the enzyme paraoxonase was drasti-
cally reduced by cadmium exposure. An 
18 % loss of enzyme activity was observed 
in the 50 ppm cadmium exposed group 
while in the 100 ppm group exposure yield-
ed a 43 % reduction in activity (Figure 3). 
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Figure 3: Paraoxonase activities in the plasma 
of rats exposed to cadmium in their drinking 
water. Values are represented as mean ± SEM, 
n=8. Bars of the same compartment carrying 
different letters of the alphabet are significantly 
different from each other (p < 0.05). 
 
 
DISCUSSION 
Evidence abound that lipid and lipopro-
tein abnormalities as well as cytokines play 
significant roles in the pathogenesis and 
progression of atherosclerosis and cardio-
vascular diseases (Ginsberg, 1994; Glew et 
al., 2002). There is also increasing evidence 
that environmental factors contribute to the-
se conditions (Aguilar-Salinas et al., 2001). 
In this study, we evaluated the effect of 
cadmium exposure on lipids and some pro-
inflammatory cytokines in rats. Cadmium 
exposure caused a dose-dependent increase 
in plasma triglyceride levels and this is as-
sociated with increased concentration of the 
TG-rich lipoproteins i.e. LDL+VLDL frac-
tion. The observed increase may, therefore, 
be a result of an increase in the hepatic syn-
thesis of TG and/or a lower clearance rate 
of TG-rich lipoproteins. Increases in both 
plasma triglyceride and LDL and VLDL 
concentrations after cadmium exposure in 
rats have been reported earlier by Larregle 
et al. (2008). They attributed the increases 
to a decreased lipoprotein lipase (LPL) ac-
tivity in the animals which resulted in an 
increase in the circulating triglyceride-rich 
VLDL. Studies have shown a strong inde-
pendent relation between plasma triglycer-
ide concentrations and the likelihood of 
cardiovascular disease (Assmann et al., 
1996). The increase in TG-rich lipoproteins 
observed in this study has been cited as one 
of the biochemical abnormalities often as-
sociated with elevated levels of triglyceride 
(Hokanson and Austin, 1996). These tri-
glyceride-rich lipoproteins and their rem-
nants, which are known to be atherogenic, 
may directly contribute to the formation of 
arterial wall foam cells (Zilversmit, 1979).  
Plasma total cholesterol contents were 
significantly elevated in this study. The ob-
served increase in plasma cholesterol was 
associated with an increase in LDL and 
VLDL cholesterol fraction in the cadmium-
treated rats. The observed increased total 
plasma cholesterol and LDL and VLDL 
cholesterol levels, and normal HDL choles-
terol levels in the rats in this study suggest 
that reverse cholesterol transport was not 
affected by cadmium exposure, but rather 
cholesterol synthesis. HMG CoA reductase 
is the rate limiting enzyme in cholesterol 
biosynthesis. The activity of this enzyme 
might have been stimulated by cadmium, 
leading to the increased cholesterol levels 
observed. The increase could partly be at-
tributed to a reduced efflux of circulatory 
VLDL cholesterol particles as a conse-
quence of a decreased LPL activity or a loss 
of LDL receptor function, leading to de-
creased LDL catabolism and elevated LDL 
levels (Twisk et al., 2000).  
Low density lipoprotein cholesterol has 
been shown to have an essential role in the 
development of atherosclerosis (Brown et 
al., 1990). This atherogenic property of 
LDL is partly a result of its oxidative modi-
fication as the uptake of oxidized low lipo-
proteins (oxLDL) has been identified as the 
major cause of foam cell formation 
(Witztum and Steinberg, 1991). In this 
study, cadmium exposure resulted in a sig-
nificant increase in the concentrations of 
oxLDL. The presence of high levels of ox-
LDL which are derived from lipid abnor-
malities and oxidative stress was accompa-
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nied with increases in lipid peroxidation 
levels in the rats. 
To examine the lipid peroxidation lev-
els, hepatic MDA concentration in all the 
groups was estimated. Cadmium at both 
doses significantly elevated the MDA con-
centrations in the liver with the highest de-
gree of lipid peroxidation obtained at the 
100 ppm dose. Another indicator of lipid 
peroxidation is the formation of hydroper-
oxides (LOOH). The present study shows 
that cadmium-induced oxidative stress also 
affects plasma lipids, as indicated by the 
high levels of LOOH. Lipoproteins account 
for the majority of plasma lipids, the results 
suggest that oxidized lipoproteins could 
contribute to the atherosclerotic process in-
duced by cadmium. This is strongly sup-
ported by the oxLDL contents obtained in 
the study. OxLDL, an atherogenic indica-
tor, was measured by analyzing baseline 
level of diene conjugation in lipid fraction 
of LDL which reportedly gives a direct and 
accurate index of oxidative stress (Cerne 
and Lukac-Bajalo, 2006). Low density lipo-
protein cholesterol has been shown to have 
an essential role in the development of ath-
erosclerosis (Brown et al., 1990). This ath-
erogenic property of LDL is partly a result 
of its oxidative modification (Witztum and 
Steinberg, 1991). In this study, cadmium 
exposure resulted in a significant increase 
in concentrations of oxLDL. This data is 
consistent with earlier studies which report 
high lipid peroxidation levels in many tis-
sues after cadmium exposure (Sacan et al., 
2007). 
Paraoxonase has been shown to be im-
portant in the metabolism of phospholipid 
and cholesteryl ester hydroperoxides, there-
by preventing the oxidation of low density 
lipoprotein (LDL) and retarding atherogen-
esis (Mackness et al., 1998). It has also 
been suggested that there is an inverse rela-
tionship between PON activity and the risk 
of cardiovascular diseases (Mackness et al., 
2003). In our study there are marked and 
significant decreases in plasma paraoxonase 
activities in the rats, following exposure to 
cadmium at two high dose levels. As 
paraoxonase is entirely complexed to HDL 
in the plasma and HDL level was not af-
fected by cadmium exposure in this study, 
the reduction in the enzyme activity could 
thus not be a consequence of a reduction in 
HDL levels, but instead, be due to reduced 
expression/synthesis of the enzyme in the 
liver.  
Another explanation is that increased 
oxidative stress may be responsible for the 
low paraoxonase activity observed during 
cadmium exposure. Aviram et al. (1999) 
have suggested that PON ability to protect 
LDL against oxidation is accompanied by 
inactivation of the enzyme, due to an inter-
action between the enzyme free sulfhydryl 
group and oxidized lipids formed during 
LDL oxidation. Accompanying this is the 
significant increase in oxLDL of the cad-
mium-exposed rats. There was also an ap-
preciable increase in the LOOH levels in 
the plasma of the animals, suggestive of an 
increase in lipid peroxidation with resultant 
oxidative stress. It has been shown that 
PON1 is sensitive to oxidation and is inac-
tivated by oxidized lipids (Aviram et al., 
1999). The decrease in plasma PON activity 
in cadmium-exposed rats might have been 
from increased inactivation of PON by an 
increased generation of reactive oxygen 
species during cadmium intoxication. From 
these data, increased LOOH levels and de-
creased paraoxonase activities may be im-
plicated in cadmium toxicity. Reduction in 
paraoxonase activities renders HDL suscep-
tible to oxidation, which may compromise 
its function (Deakin et al., 2007). Several 
studies suggest that a low-level plasma 
PON1 activity is associated with increased 
prevalence of atherosclerosis and could be 
an independent risk factor for coronary 
events (Mackness et al., 1998). Proinflam-
matory cytokines such as TNF-α have been 
shown to down-regulate mRNA expression 
of PON1 in HepG2 cells (Kumon et al., 
2002). The increase in the proinflammatory 
cytokine levels may thus partly be respon-
sible for the reduction in plasma PON1 ac-
tivity seen in our study. 
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Cadmium intoxication caused increased 
expressions of IL-2, IL-6 and TNF-α in the 
animals. A similar result was reported by 
Villanueva et al. (2000) where cadmium 
exposure led to increased production of 
TNF-α and IL-6. The elevations of these 
proinflammatory cytokines could be due in 
part, to an increase in ox-LDL caused by 
cadmium. oxLDL has chemoattractant ac-
tivity on monocytes and it promotes their 
differentiation into macrophages (Quinn et 
al., 1987). Its binding to CD36 has been 
reported to trigger the release of proin-
flammatory cytokines in macrophages 
(Janabi et al., 2000). Atherosclerosis is 
widely recognized as an inflammatory dis-
ease involving large arteries (Glass and 
Witztum, 2001; Hansson, 2005). The in-
crease in the levels of these proinflammato-
ry cytokines could tilt the balance between 
them and the anti-inflammatory cytokines, 
increasing the atherogenic potential in the 
system. The activation of NK-κB in macro-
phages is also known to control the expres-
sion of proinflammatory cytokines, such as 
IL-6 and TNF-α (Monaco et al., 2004). NK-
κB is a redox-sensitive transcription factor; 
the increase in oxidative stress induced by 
cadmium could have, therefore, favored its 
activation in the animals. This could have 
resulted in the elevated levels of IL-6 and 
TNF-α seen in our study. IL-6 and TNF-α 
production have significant correlation with 
development of atherosclerosis and have 
been implicated as an atherosclerotic indi-
cator (Haddy et al., 2003). 
IL-6 can act as both pro-inflammatory 
and anti-inflammatory cytokine, depending 
on its level of expression (Febbraio and 
Pedersen, 2005). IL-6 is required for re-
sistance against infections, however, at high 
concentrations, it has been implicated in 
pathological conditions such as increased 
risk of atherosclerosis and heart attack (Du-
binski and Zdrojewicz, 2007). IL-6 is one 
of the most consistent biomarker of peri-
pheral arterial disease (PAD) because it en-
hances cell adhesion molecule (CAM) ex-
pression by endothelial and smooth muscle 
cells, and also, the production of acute 
phase reactants such as C-reactive protein 
and TNF-α by the hepatocytes. It correlates 
with metabolic and inflammatory factors 
(CRP and TNF-α) which are considered 
relevant to atherosclerotic progression 
(Haddy et al., 2003). It has also been impli-
cated in the progression of stimulated 
smooth muscle cells into foam cells (von 
der Thusen et al., 2003). Zahid et al. (2007) 
reported a reciprocal regulation of IL-6 by 
TNF-α at high concentrations. The increase 
observed in serum IL-6 levels in rats ad-
ministered cadmium at the doses of 50 and 
100 ppm could thus, be due to this recipro-
cal regulation of this cytokine by TNF-α. 
On the other hand, TNF-α has been as-
sociated with an elevated risk of recurrent 
myocardial infarction and cardiovascular 
death (Ridker et al., 2000). Its levels also 
correlate with the burden of atherosclerosis 
(Bruunsgaard et al., 1999). TNF-α has been 
shown to alter the distribution of adhesion 
receptors involved in cell-cell adhesion, 
preventing the formation of F-actin stress 
fibers. The resulting restructuring of the 
intercellular junction eventual leads to loss 
of endothelial permeability, favoring leuko-
cyte transmigration (Wojciak-Stothard et 
al., 1998). The dose dependent increase in 
TNF-α concentration strengthens the fact 
that cadmium intoxication induced inflam-
matory responses in the rats, which could 
have been a result of oxidative stress. 
IL-2 plays a role integral in vascular in-
flammatory processes. It is found to be ex-
pressed in atherosclerotic plaques and a 
study had shown that intraperitoneal injec-
tions of IL-2 increased lesion size in mice 
fed atherogenic diet (Upadhya et al., 2004). 
Increase in IL-2 concentration has been 
shown to sensitize the expression of IL-2 
receptors (IL-2R) on cells and IL-2/IL-2R 
interaction are reported to induce the prolif-
eration, differentiation, maturation and sur-
vival of antigen-selected cytotoxic T cells 
via the activation of the expression of spe-
cific genes (Beadling and Smith, 2002). 
Although the increase in dose of adminis-
tered cadmium did not aggravate the severi-
ty of the expression of IL-2, the administra-
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tion of cadmium to rat must have emanated 
into systemic and/or localized inflammation 
that triggered immunological response. 
The study demonstrated that the toxicity 
of cadmium may partly be due to its disrup-
tion of lipid metabolism in addition to a 
perturbation of proinflammatory cytokine 
levels. The exposure resulted in modulation 
of cholesterol homeostasis as well as inter-
ference with lipid transport. Some of these 
dysfunctional states elicited by cadmium 
may be linked to its ability to induce oxida-
tive stress in cellular systems, giving rise to 
both systemic and localized inflammatory 
responses. 
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